DNAprint Genomics (DNAG)

[dgplexus]

"frogdreaming,"

Firstly, that was not the last 8K (you claimed to be talking about the last 8K.)

Secondly, the 8K you now cite does not say what you claimed, either, which was:

"They explained how they had abandoned all of the licenses they were working on and allowed them to default to their owners. They explained how they could not obtain financing and had given up on the attempt to spin off a pharmaceutical division. (A moot point given that they had already defaulted on the licenses that were the foundation of any pharmaceutical effort.)"

Thirdly, you have not addressed the issue, that you falsely claimed "distributors" (plural) dropped DNAPrint Genomics' products due to "lack of sales." The only example you offered does NOT support your claim, as Sam's rebuttal makes perfectly clear.

By the way, the 8K you linked to is more readable here (the right side of the page is not chopped off, here) :
http://www.sec.gov/Archives/edgar/data/1127354/000135448808000259/f8k.htm

I am not disputing anything in any of DNAPrint Genomics' filings. I am disputing these specific claims that _you_ made. Will you not face your untrue statements, that you used against DNAG?

For reference, the original message in which I asked you to address these untrue statements:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=31981807